An Overview the Role of Pharmacology in Managing Post-COVID-19 Complications

Abstract

Infections caused by severe acute respiratory syndrome coronavirus 2 are alarming globally, resulting in significant loss of life and property. Individuals are confronting a dire pandemic situation due to the lack of suitable medications to address severe acute respiratory syndrome coronavirus 2 infections. This review sought to elucidate the pharmacological interventions implemented globally to combat the COVID-19 pandemic. Drug repositioning is a viable method, with several medications having been repurposed, including lopinavir/ritonavir, remdesivir, favipiravir, and tocilizumab. This research delineates the primary pharmacological characteristics of medicines administered to COVID-19 patients, emphasizing their antiviral, immunomodulatory, and/or anti-inflammatory effects.